{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:50:12Z","timestamp":1793829012749,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.humpath.2013.12.011","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T02:00:44Z","timestamp":1389146444000},"page":"976-983","source":"Crossref","is-referenced-by-count":42,"title":["Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up"],"prefix":"10.1016","volume":"45","author":[{"given":"Nafis","family":"Shafizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Genrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.12.011_bb0005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0015","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.3499668","article-title":"Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters","volume":"238","author":"Courtois","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.humpath.2013.12.011_bb0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng1001","article-title":"Bi-allelic inactivation of TCF1 in hepatic adenomas","volume":"32","author":"Bluteau","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2013.12.011_bb0025","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.gastro.2003.07.012","article-title":"Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation","volume":"125","author":"Bacq","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0030","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jc.2003-031552","article-title":"Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families","volume":"89","author":"Reznik","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.12.011_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","article-title":"Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours","volume":"457","author":"Rebouissou","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2013.12.011_bb0040","doi-asserted-by":"crossref","unstructured":"Joseph NM, Ferrell LD, Jain D, et al. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Mod Pathol 2013 Jun 28; http:\/\/dx.doi.org\/10.1038\/modpathol.2013.114.","DOI":"10.1038\/modpathol.2013.114"},{"key":"10.1016\/j.humpath.2013.12.011_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.21684","article-title":"Telangiectatic adenoma: an entity associated with increased body mass index and inflammation","volume":"46","author":"Paradis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.humpath.2012.07.019","article-title":"Atypical hepatocellular adenoma-like neoplasms with beta-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas","volume":"44","author":"Evason","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/268625","article-title":"Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of immunopathologic classification","volume":"2013","author":"Balabaud","year":"2013","journal-title":"International Journal of Hepatology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0060","doi-asserted-by":"crossref","first-page":"604860","DOI":"10.1155\/2013\/604860","article-title":"Changing epidemiology of hepatocellular adenoma in the United States: review of the literature","volume":"2013","author":"Chang","year":"2013","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0065","first-page":"679","article-title":"Liver pathology: cirrhosis, hepatitis, and primary liver tumors","volume":"13","author":"Ferrell","year":"2000","journal-title":"Update and diagnostic problems. Mod Pathol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0070","doi-asserted-by":"crossref","unstructured":"Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995 Sep;22:983\u201393.","DOI":"10.1002\/hep.1840220341"},{"key":"10.1016\/j.humpath.2013.12.011_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e3182653ece","article-title":"Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes","volume":"36","author":"Bioulac-Sage","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0080","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: 2010."},{"key":"10.1016\/j.humpath.2013.12.011_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M","article-title":"Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1","volume":"30","author":"Balsara","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2013.12.011_bb0090","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2006.08.014","article-title":"A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data","volume":"131","author":"Poon","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2559.2009.03343.x","article-title":"Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms","volume":"55","author":"Kakar","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.12.011_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1525-1578(10)60654-X","article-title":"Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma","volume":"3","author":"Wilkens","year":"2001","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2013.12.011_bb0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/path.825","article-title":"Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization","volume":"193","author":"Wilkens","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/path.2169","article-title":"Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations","volume":"212","author":"Audard","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2013.12.011_bb0115","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/1078-0432.CCR-09-1978","article-title":"Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation","volume":"16","author":"Dal","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.12.011_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","article-title":"Changing trends in malignant transformation of hepatocellular adenoma","volume":"60","author":"Farges","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2013.12.011_bb0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1478-3231.2008.01849.x","article-title":"Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology","volume":"29","author":"Bioulac-Sage","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2013.12.011_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/RCT.0b013e31820bad61","article-title":"Hepatocellular adenomas: current update on genetics, taxonomy, and management","volume":"35","author":"Shanbhogue","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.humpath.2013.12.011_bb0135","series-title":"Expression of liver fatty acid binding protein (LFABP) in hepatocellular carcinomas","author":"Cho","year":"2013"},{"key":"10.1016\/j.humpath.2013.12.011_bb0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/his.12011","article-title":"The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre","volume":"62","author":"Bellamy","year":"2013","journal-title":"Histopathology"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T11:24:24Z","timestamp":1538911464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0046817714000100"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.12.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}